ARTICLE | Company News
IntraBiotics, Pharmacia & Upjohn deal
April 15, 2013 7:00 AM UTC
The companies will develop and commercialize IntraBiotics' IB-367 topical protegrin antimicrobial compound, which is in Phase I trials to treat and prevent oral mucositis due to chemotherapy and radia...